| A Study of the Efficacy of Intravenous Esketamine in Adult Patients With Treatment-Resistant Depression (NCT01640080) | Janssen Research & Development, LLC | 2012-06-27 |
| A Positron Emission Topographic (PET) Study on Depression Patient With Electroacupuncture (NCT01479920) | The University of Hong Kong | 2012-06-01 |
| PET Imaging of mGLuR5 With Drug Challenge (NCT01691092) | Yale University | 2012-06-01 |
| LEPR Polymorphism Weight Gain by Mirtazapine in Late Life Depression (NCT01601002) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2012-06-01 |
| Ketamine in the Treatment of Suicidal Depression (NCT01700829) | New York State Psychiatric Institute | 2012-06-01 |
| Anti-INFLammatory to Address Mood and Endothelial Dysfunction (INFLAMED) (NCT01625845) | Indiana University | 2012-06-01 |
| Dose-Ranging Trial of Creatine Augmentation for Adolescent Females With Treatment-Resistant Major Depressive Disorder (NCT01601210) | Perry Renshaw | 2012-06-01 |
| Algorithm Guided Treatment Strategies for Major Depressive Disorder (NCT01764867) | Shanghai Mental Health Center | 2012-06-01 |
| Lexapro®'s Efficacy After Dose Escalation in Remission Study (NCT01594866) | Seoul National University Hospital | 2012-05-01 |
| Major Depressive Disorder - Understanding The Link Between The Brain And The Heart (NCT01568307) | Baker Heart and Diabetes Institute | 2012-05-01 |
| Exploratory Study on the Mood and Cytokine Levels in Female Healthy Participants and Major Depressive Disorder Patients (NCT01533285) | Janssen Pharmaceutica N.V., Belgium | 2012-05-01 |
| Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder (NCT01370733) | Wave Neuroscience | 2012-05-01 |
| The Metabolic Effects of Antidepressants in Patients Diagnosed With Major Depressive Disorder (NCT01418638) | Ziv Hospital | 2012-05-01 |
| Study of Vortioxetine (Lu AA21004) in Major Depressive Disorder in Asian Countries (NCT01571453) | H. Lundbeck A/S | 2012-05-01 |
| Canadian Biomarker Integration Network for Depression Study (NCT01655706) | University Health Network, Toronto | 2012-04-23 |
| Safety and Efficacy of Vilazodone in Major Depressive Disorder (NCT01573598) | Forest Laboratories | 2012-04-01 |
| Ketamine Infusion for Treatment-resistant Major Depressive Disorder (NCT01582945) | Massachusetts General Hospital | 2012-04-01 |
| EMR Data to Assess Monitoring of Patients Treated With Quetiapine (NCT01793324) | AstraZeneca | 2012-04-01 |
| Potential Use Of Brain Network Activation Analysis to Diagnose Major Depression (NCT01579942) | Massachusetts General Hospital | 2012-04-01 |
| Iloperidone Augmentation of SSRIs for Patients With Major Depressive Disorder With Residual Anger and Irritability (NCT01464229) | Maurizio Fava, MD | 2012-04-01 |
| Comparison of Plasma Concentration Changes Between Two Types of Tablets of FK949E Administration to Patients With Major Depressive Disorder (NCT01919008) | Astellas Pharma Inc | 2012-03-26 |
| Effects of Seroquel XR on Sleep Architecture in Patients With Major Depressive Disorder (NCT01189318) | Ewha Womans University | 2012-03-01 |
| Glutamatergic and GABAergic Mediators of Antidepressant Response in Major Depression (NCT01557946) | Mclean Hospital | 2012-03-01 |
| Study of Technology-assisted Treatment of Adolescent Depression (NCT01582581) | iHope Network, Inc. | 2012-03-01 |
| Therapeutic Effectiveness of Exercise Associated to the Pharmacotherapy in Major Depression (NCT02427789) | University of Sao Paulo General Hospital | 2012-03-01 |
| Estimate the Efficiency of the Association of an Injection of Ketamine and the Venlafaxine in the Severe Major Depressive Disorder for Six Weeks (NCT01557712) | University Hospital, Grenoble | 2012-03-01 |
| Contingency Management of Alcohol Abuse in the Severely Mentally ILL (NCT01567943) | University of Washington | 2012-03-01 |
| Desvenlafaxine Succinate (Pristiq): Postmarketing Surveillance Study Among Filipino Patients (NCT01353963) | Pfizer | 2012-03-01 |
| TF-CBT for Long-term PTSD, Major Depressive Disorder and Anxiety Disorders in Victims of Terrorism (NCT05516368) | Universidad Complutense de Madrid | 2012-03-01 |
| Clinical Trial of the Effectiveness of Metacognitive Therapy in the Treatment of Patients With Major Depressive Disorder (NCT01608399) | Norwegian University of Science and Technology | 2012-03-01 |
| SPD489 Adult Major Depressive Disorder (MDD) Open-label Safety and Tolerability Rollover Extension Study (NCT01436175) | Shire | 2012-02-27 |
| Blood Biomarkers in Major Depression (NCT02209142) | Assistance Publique Hopitaux De Marseille | 2012-02-22 |
| Examination of Glutamate and mGluR5 in Psychiatric Disorders (NCT02727972) | Yale University | 2012-02-21 |
| Aripiprazole (Abilify®) as an Adjunctive Treatment for Inadequate Response in Major Depressive Disorder (NCT01696617) | Seoul National University Hospital | 2012-02-10 |
| A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDD (NCT01371708) | Pfizer | 2012-02-02 |
| A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD (NCT01371721) | Pfizer | 2012-02-01 |
| Study of Ketamine as an Antidepressant in Major Depressive Disorder (NCT01573741) | Shi Jinyun | 2012-02-01 |
| Evaluation of a Stepped Care Approach to Manage Depression in Diabetes (NCT01812291) | Forschungsinstitut der Diabetes Akademie Mergentheim | 2012-02-01 |
| Transcranial Laser Therapy for Major Depressive Disorder (NCT01538199) | Paolo Cassano | 2012-02-01 |
| ON/OFF Stimulation and Impulsivity in Patients With Deep Brain Stimulators (NCT01506206) | Massachusetts General Hospital | 2012-02-01 |
| Ketamine in the Treatment of Depression (NCT01558063) | Columbia University | 2012-02-01 |
| Stimulant Enhancement of Well-Being Therapy for Depression (NCT01478113) | Massachusetts General Hospital | 2012-02-01 |
| Efficacy and Safety Study of ABT-436 in Major Depressive Disorder (NCT01741142) | AbbVie (prior sponsor, Abbott) | 2012-01-01 |
| Oxytocin and Tibolone Adjuncts in Treatment Resistant Depression - A Pilot Study (NCT01239888) | The Alfred | 2012-01-01 |
| Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD) (NCT01485887) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2012-01-01 |
| Depression and Dopamine Transporter Function Study Using C-11 Altropane (NCT01701141) | Mclean Hospital | 2012-01-01 |
| Neurocognition and Work Productivity in Major Depressive Disorder (MDD) (NCT01468610) | University of British Columbia | 2012-01-01 |
| Major Depressive Disorder With Mixed Features (NCT01423240) | Sumitomo Pharma America, Inc. | 2012-01-01 |
| A Study of Vortioxetine (Lu AA21004) in Comparison to Agomelatine in Adults Suffering From Major Depression With Inadequate Response to Previous Medication (NCT01488071) | H. Lundbeck A/S | 2012-01-01 |
| A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder (NCT01482221) | AstraZeneca | 2011-12-16 |
| Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder (NCT01469377) | Forest Laboratories | 2011-12-15 |
| African American Depression Intervention Trial (AADI) (NCT01342536) | University of Wisconsin, Madison | 2011-12-14 |
| Study to Evaluate the Effect and Safety of Quetiapine Extended Release (XR) (FK949E) in Major Depressive Disorder (NCT01725282) | Astellas Pharma Inc | 2011-12-14 |
| Effectiveness of Interpersonal Psychotherapy (IPT) for Men and Women Prisoners With Major Depression (NCT01685294) | Brown University | 2011-12-01 |
| Safety, Efficacy, and Tolerability of Vilazodone in Major Depressive Disorder (NCT01473394) | Forest Laboratories | 2011-12-01 |
| Effect of Physical Activity on Depressive Symptoms With a 5 Month Follow-up (NCT01995422) | Laboratory Motricité, Interactions, Performance | 2011-12-01 |
| Study of Repetitive Transcranial Magnetic Stimulation (rTMS) in Depressed Teens (NCT01502033) | Paul E. Croarkin | 2011-12-01 |
| Acceptance and Commitment Therapy Versus Cognitive Therapy for the Treatment of Major Depressive Disorder (NCT01517503) | VU University of Amsterdam | 2011-12-01 |
| ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment (NCT01457677) | Hoffmann-La Roche | 2011-12-01 |
| A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD) (NCT01500200) | Alkermes, Inc. | 2011-12-01 |
| Efficacy Study of Vortioxetine on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder (NCT01422213) | H. Lundbeck A/S | 2011-12-01 |
| Safety and Efficacy of Vilazodone in Major Depressive Disorder (NCT01473381) | Forest Laboratories | 2011-12-01 |
| Life Goals Collaborative Care to Improve Health Outcomes in Mental Disorders (NCT01487668) | VA Office of Research and Development | 2011-12-01 |
| Magnetic Resonance Imaging Study of Cognitive-Behavior Therapy for Major Depressive Disorder (NCT01460212) | Nanjing Medical University | 2011-12-01 |
| A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD (NCT01372150) | Pfizer | 2011-11-17 |
| Beat the Blues in Pregnancy Study - Transcranial Magnetic Stimulation (NCT01492309) | University of Pennsylvania | 2011-11-01 |
| Mindfulness Based Cognitive Therapy for Chronic Pain and Comorbid Unipolar Depression (NCT01473615) | Massachusetts General Hospital | 2011-11-01 |
| Cognitive Therapy for Unipolar Depression: Efficacy of a Dilemma-Focused Intervention (NCT01542957) | University of Barcelona | 2011-11-01 |
| Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD) (NCT01441440) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2011-11-01 |
| Pharmacokinetics and Safety of Desvenlafaxine in Korean Healthy Subjects Following Single and Multiple Oral Doses of Desvenlafaxine Succinate Sustained Release Tablet (NCT01443208) | Pfizer | 2011-11-01 |
| Pioglitazone in Patients With Mood Disorders (NCT01559857) | Stanford University | 2011-11-01 |
| Mechanism of Action of Transcranial Magnetic Stimulation (NCT04278521) | Massachusetts General Hospital | 2011-11-01 |
| Mindfulness-Based Cognitive Therapy Effect on Depression and C-Reactive Protein Levels After 8 Weeks of Treatment (NCT02385786) | University of California, San Francisco | 2011-11-01 |
| Complex Dynamic Systems in Mood Disorders (NCT01583569) | Massachusetts General Hospital | 2011-11-01 |
| Badalona Major Depressive Disorder Database Study (NCT01446692) | AstraZeneca | 2011-11-01 |
| Aripiprazole Augmentation Versus Switching to Different Class of Antidepressants in Major Depressive Disorder (NCT01488266) | Korea University | 2011-11-01 |
| Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder (NCT01436149) | Shire | 2011-10-27 |
| Patient Characteristics and Cognitive vs. Behavioral Therapies for Depression (NCT04529694) | Ohio State University | 2011-10-20 |
| Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder (NCT01436162) | Shire | 2011-10-19 |
| Early Intervention for Youth at Risk for Bipolar Disorder (NCT01483391) | University of California, Los Angeles | 2011-10-06 |
| Pilot Study in Multi-Coil Repetitive Transcranial Magnetic Stimulation (rTMS) for Treatment Resistant Depression (NCT01431001) | Cervel Neurotech, Inc. | 2011-10-01 |
| Effectiveness of Deep Transcranial Magnetic Stimulation in Depression (NCT01409304) | Douglas Mental Health University Institute | 2011-10-01 |
| MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy (NCT01437657) | Hoffmann-La Roche | 2011-10-01 |
| Intranasal Ketamine in Treatment-Resistant Depression (NCT01304147) | James Murrough | 2011-10-01 |
| Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) in Adult Outpatients With Major Depressive Disorder (MDD) (NCT01432457) | Pfizer | 2011-10-01 |
| The Serotonin Transporter Availability for Prognosing Major Depressive Disorder (MDD) Treatment and Detecting MDD (NCT02473783) | Tri-Service General Hospital (TSGH) | 2011-10-01 |
| The Effect of IPS-MA- A Modified Early Supported Employment Intervention for Individuals With Mood or Anxiety Disorders (NCT01721824) | Amager Hospital | 2011-10-01 |
| Adaptation of Dialectical Behavior Therapy Skills-Groups for Individuals With Suicidal Ideation and Depression (NCT01441258) | Maurizio Fava, MD | 2011-10-01 |
| Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in Major Depressive Disorder (MDD) (NCT01312922) | PharmaNeuroBoost N.V. | 2011-09-01 |
| Major Depressive Disorder With Mixed Features - Extension (NCT01423253) | Sumitomo Pharma America, Inc. | 2011-09-01 |
| Aripiprazole for the Augmentation of Antidepressant Therapy (NCT01429831) | Taiwan Otsuka Pharm. Co., Ltd | 2011-09-01 |
| Melatonin Agonist Effects of Tasimelteon Versus Placebo in Patients With Major Depressive Disorder (NCT01428661) | Vanda Pharmaceuticals | 2011-09-01 |
| Pharmacogenomics for Antidepressant Guidance and Education 1 (PAGE-1_AG1) (NCT01426516) | Genomind, LLC | 2011-09-01 |
| Measuring Adherence to Medication for Depression and Attention-deficit Hyperactivity Disorder (NCT01430767) | Wake Forest University Health Sciences | 2011-09-01 |
| A Stepped Care Model of Adolescent Depression Treatment in Primary Care (NCT01443715) | New York State Psychiatric Institute | 2011-09-01 |
| Lithium Versus Paroxetine in Major Depression (NCT01416220) | Nova Scotia Health Authority | 2011-09-01 |
| Description of Treatment Management of Patients With Major Depressive Disorder and Inadequate Response (NCT01397903) | AstraZeneca | 2011-09-01 |
| Decreasing the Use of Unmodified Electroconvulsive Therapy (ECT) in an Indian Hospital (NCT01526395) | Johns Hopkins University | 2011-08-01 |
| Maintenance NeuroStar Transcranial Magnetic Stimulation (TMS) in Patients With Major Depressive Disorder (NCT01415154) | Neuronetics | 2011-08-01 |
| Exploring Biomarkers for Depression (NCT01424111) | Wyss Institute at Harvard University | 2011-08-01 |